GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 5 filers reported holding GUARDANT HEALTH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,964 | -17.2% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $3,579 | +52.7% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $2,344 | -99.4% | 100 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $364,371 | -86.0% | 13,396 | -72.3% | 0.00% | -85.7% |
| Q3 2022 | $2,605,000 | -25.3% | 48,400 | -44.0% | 0.03% | -20.0% |
| Q2 2022 | $3,485,000 | +18242.1% | 86,400 | +28700.0% | 0.04% | – |
| Q1 2022 | $19,000 | -99.7% | 300 | -99.5% | 0.00% | -100.0% |
| Q4 2021 | $5,681,000 | -18.6% | 56,800 | +1.8% | 0.05% | -11.7% |
| Q3 2021 | $6,975,000 | +0.2% | 55,800 | -0.5% | 0.06% | +13.2% |
| Q2 2021 | $6,963,000 | -17.8% | 56,075 | +1.0% | 0.05% | -26.4% |
| Q1 2021 | $8,472,000 | +18.5% | 55,500 | 0.0% | 0.07% | +35.8% |
| Q4 2020 | $7,152,000 | +2558.7% | 55,500 | +2204.8% | 0.05% | +2550.0% |
| Q3 2020 | $269,000 | +31.2% | 2,408 | -4.8% | 0.00% | 0.0% |
| Q2 2020 | $205,000 | – | 2,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |